Skip to content

MyMenoPlan: Online Resource for Improving Women's Menopause Knowledge and Informed Decision-making

MsFLASH: Living a Healthy Menopause, Aim 2 Randomized Controlled Trial of MyMenoPlan

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05299983
Enrollment
410
Registered
2022-03-29
Start date
2022-01-15
Completion date
2022-03-31
Last updated
2025-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause, Postmenopause, Premenopause

Keywords

Computer-Assisted Decision Making, Internet-Based Intervention

Brief summary

As part of a National Institute on Aging -funded R01, the investigators developed an evidence-based, multi-media digital resource entitled MyMenoPlan to help women learn about the menopause transition, and the symptoms and treatments of perimenopause/menopause. MyMenoPlan is also designed to help women learn about the effectiveness of treatments for a comprehensive list of midlife symptoms and compare treatments that may help with the specific symptoms women are experiencing.

Detailed description

The purpose of this research study is to: 1. Investigate how women randomly assigned to visit MyMenoPlan use the website (time spent on website, treatment and symptom page views, use of interactive tools, and use of the MyMenoPlan tool). 2. Compare the ratings of women randomly assigned to MyMenoPlan to those randomly assigned to other menopause websites for perceived quality of information, readability, self-efficacy, and credibility of these online menopause resources.

Interventions

OTHERMyMenoPlan

Participants are asked to spend at least 20 minutes on the website (MyMenoPlan) assigned to them.

OTHERControl

Participants are asked to spend at least 20 minutes on at least one of the following websites: 1. North American Menopause Society: https://www.menopause.org/for-women 2. National Institute on Aging: https://www.nia.nih.gov/health/topics/menopause 3. The Office on Women's Health-Menopause: https://www.womenshealth.gov/menopause

Sponsors

University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* As stated above

Exclusion criteria

* N/A

Design outcomes

Primary

MeasureTime frameDescription
Perceived Quality of InformationEach survey question is answered after spending at least 20 minutes on the assigned website(s)This 7-item, 5-point Likert scale (1- Strongly disagree to 5 - Strongly agree) is adapted from the Post-Study System Usability Questionnaire (PSSUQ) in Lewis (1995). The range of this scale is 1-5. The items in this scale were averaged with a higher score meaning higher on this outcome (perceived quality of information). Items: 1. Reading the information made me feel in more control of my perimenopause/menopause. 2. The information on the website(s) was helpful to me. 3. I found the information I was looking for. 4. The information answered my questions about perimenopause/menopause. 5. I liked the website (s). 6. I would have liked more in-depth information. (reverse-coded) 7. The website(s) were fairly comprehensive about perimenopause /menopause.
ReadabilityEach survey question is answered after spending at least 20 minutes on the assigned website(s)This 2-item, 5-point Likert (1- Strongly disagree to 5 - Strongly agree)scale was derived from the Standardized User Experience Percentile Rank Questionnaire (SUPR-Q) in Sauro (1995). The range of this scale is 1-5. The items in this scale were averaged with a higher score meaning higher on this outcome (readability). Items: 1. The information I read was clear. 2. The information I read was easy for me to understand.
Self-Efficacy for Managing Menopause SymptomsEach survey question is answered after spending at least 20 minutes on the assigned website(s)This is a newly developed Likert scale (1- Strongly disagree to 5 - Strongly agree) for assessing participants' beliefs in their own abilities in managing menopausal symptoms. The range of this scale is 1-5. The items in this scale were averaged with a higher score meaning higher on this outcome (self-efficacy). Items: 1. If I want to, I am certain I could figure out the treatments or coping strategies that would work best for me. 2. I feel I could treat or cope with my symptoms of perimenopause/menopause if I want to.
CredibilityEach survey question is answered after spending at least 20 minutes on the assigned website(s)This 2-item, 5-point Likert (1- Strongly disagree to 5 - Strongly agree) scale was derived from the Standardized User Experience Percentile Rank Questionnaire (SUPR-Q) in Sauro (1995). The range of this scale is 1-5. The items in this scale were averaged with a higher score meaning higher on this outcome (credibility). Items: 1. The information is credible. 2. The information is trustworthy.

Countries

United States

Participant flow

Pre-assignment details

Eligibility screening and quality control checks resulted in exclusion of 503. Internet recruited studies requires careful quality control checks for fraudulent participants.

Participants by arm

ArmCount
MyMenoPlan
Participants are asked to spend at least 20 minutes on the website (MyMenoPlan) assigned to them. MyMenoPlan: Participants are asked to spend at least 20 minutes on the website (MyMenoPlan) assigned to them.
200
Control
Participants are asked to spend at least 20 minutes on at least one of the following websites or other websites of their choice: 1. North American Menopause Society: https://www.menopause.org/for-women 2. National Institute on Aging: https://www.nia.nih.gov/health/topics/menopause 3. The Office on Women's Health-Menopause: https://www.womenshealth.gov/menopause Control: Participants are asked to spend at least 20 minutes on at least one of the following websites: 1. North American Menopause Society: https://www.menopause.org/for-women 2. National Institute on Aging: https://www.nia.nih.gov/health/topics/menopause 3. The Office on Women's Health-Menopause: https://www.womenshealth.gov/menopause
210
Total410

Baseline characteristics

CharacteristicMyMenoPlanControlTotal
Age, Continuous49.1 years
STANDARD_DEVIATION 4
49.4 years
STANDARD_DEVIATION 3.8
49.3 years
STANDARD_DEVIATION 3.91
Difficulty paying for basics
A lot
30 Participants31 Participants61 Participants
Difficulty paying for basics
None
105 Participants93 Participants198 Participants
Difficulty paying for basics
Some
63 Participants83 Participants146 Participants
Difficulty paying for basics
Unknown
2 Participants3 Participants5 Participants
Education
College graduate
46 Participants42 Participants88 Participants
Education
High school or less
23 Participants42 Participants65 Participants
Education
Post-graduate degree
50 Participants37 Participants87 Participants
Education
Some college or vocational training
81 Participants87 Participants168 Participants
Education
Unknown
0 Participants2 Participants2 Participants
Education (years)15.2 years
STANDARD_DEVIATION 2.3
14.7 years
STANDARD_DEVIATION 2.3
14.96 years
STANDARD_DEVIATION 2.29
Menopause Stage
Don't know - hysterectomy but kept ovaries
8 Participants9 Participants17 Participants
Menopause Stage
Don't know - IUD
9 Participants10 Participants19 Participants
Menopause Stage
Perimenopause
109 Participants102 Participants211 Participants
Menopause Stage
Postmenopause
54 Participants66 Participants120 Participants
Menopause Stage
Premenopause
18 Participants23 Participants41 Participants
Menopause Stage
Unknown
2 Participants0 Participants2 Participants
Race/Ethnicity, Customized
Asian
2 Participants6 Participants8 Participants
Race/Ethnicity, Customized
Black
18 Participants28 Participants46 Participants
Race/Ethnicity, Customized
Hispanic
9 Participants8 Participants17 Participants
Race/Ethnicity, Customized
Multiethnic
12 Participants9 Participants21 Participants
Race/Ethnicity, Customized
Native American, Native Hawaiian, Pacific Islander
3 Participants3 Participants6 Participants
Race/Ethnicity, Customized
Other
2 Participants2 Participants4 Participants
Race/Ethnicity, Customized
Unknown/not reported
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
White
153 Participants154 Participants307 Participants
Sex: Female, Male
Female
200 Participants210 Participants410 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 2000 / 210
other
Total, other adverse events
0 / 2000 / 210
serious
Total, serious adverse events
0 / 2000 / 210

Outcome results

Primary

Credibility

This 2-item, 5-point Likert (1- Strongly disagree to 5 - Strongly agree) scale was derived from the Standardized User Experience Percentile Rank Questionnaire (SUPR-Q) in Sauro (1995). The range of this scale is 1-5. The items in this scale were averaged with a higher score meaning higher on this outcome (credibility). Items: 1. The information is credible. 2. The information is trustworthy.

Time frame: Each survey question is answered after spending at least 20 minutes on the assigned website(s)

ArmMeasureValue (MEAN)Dispersion
MyMenoPlanCredibility4.3 score on a scaleStandard Deviation 0.66
ControlCredibility4.4 score on a scaleStandard Deviation 0.65
p-value: 0.45Chi-squared
Primary

Perceived Quality of Information

This 7-item, 5-point Likert scale (1- Strongly disagree to 5 - Strongly agree) is adapted from the Post-Study System Usability Questionnaire (PSSUQ) in Lewis (1995). The range of this scale is 1-5. The items in this scale were averaged with a higher score meaning higher on this outcome (perceived quality of information). Items: 1. Reading the information made me feel in more control of my perimenopause/menopause. 2. The information on the website(s) was helpful to me. 3. I found the information I was looking for. 4. The information answered my questions about perimenopause/menopause. 5. I liked the website (s). 6. I would have liked more in-depth information. (reverse-coded) 7. The website(s) were fairly comprehensive about perimenopause /menopause.

Time frame: Each survey question is answered after spending at least 20 minutes on the assigned website(s)

ArmMeasureValue (MEAN)Dispersion
MyMenoPlanPerceived Quality of Information4.1 score on a scaleStandard Deviation 0.59
ControlPerceived Quality of Information3.7 score on a scaleStandard Deviation 0.73
p-value: <0.001Chi-squared
Primary

Readability

This 2-item, 5-point Likert (1- Strongly disagree to 5 - Strongly agree)scale was derived from the Standardized User Experience Percentile Rank Questionnaire (SUPR-Q) in Sauro (1995). The range of this scale is 1-5. The items in this scale were averaged with a higher score meaning higher on this outcome (readability). Items: 1. The information I read was clear. 2. The information I read was easy for me to understand.

Time frame: Each survey question is answered after spending at least 20 minutes on the assigned website(s)

ArmMeasureValue (MEAN)Dispersion
MyMenoPlanReadability4.6 score on a scaleStandard Deviation 0.52
ControlReadability4.4 score on a scaleStandard Deviation 0.67
p-value: 0.02Chi-squared
Primary

Self-Efficacy for Managing Menopause Symptoms

This is a newly developed Likert scale (1- Strongly disagree to 5 - Strongly agree) for assessing participants' beliefs in their own abilities in managing menopausal symptoms. The range of this scale is 1-5. The items in this scale were averaged with a higher score meaning higher on this outcome (self-efficacy). Items: 1. If I want to, I am certain I could figure out the treatments or coping strategies that would work best for me. 2. I feel I could treat or cope with my symptoms of perimenopause/menopause if I want to.

Time frame: Each survey question is answered after spending at least 20 minutes on the assigned website(s)

ArmMeasureValue (MEAN)Dispersion
MyMenoPlanSelf-Efficacy for Managing Menopause Symptoms4.0 score on a scaleStandard Deviation 0.66
ControlSelf-Efficacy for Managing Menopause Symptoms3.9 score on a scaleStandard Deviation 0.71
p-value: 0.22Chi-squared

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026